首页 | 本学科首页   官方微博 | 高级检索  
     


Long-standing type 1 diabetes: patients with adult-onset develop celiac-specific immunoreactivity more frequently than patients with childhood-onset diabetes,in a disease duration-dependent manner
Authors:Claudio Tiberti  Francesca Panimolle  Margherita Bonamico  Tiziana Filardi  Lucia Pallotta  Raffaella Nenna  Stefano Pontone  Francesco Dotta  Giuseppe Pugliese  Andrea Lenzi  Stefano Balducci  Susanna Morano
Affiliation:1. Department of Internal Medicine, Policlinico Umberto I, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy
2. Department of Pediatrics, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy
3. Department of Surgical Sciences, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy
6. Diabetes Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy
4. Department of Clinical and Molecular Medicine, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy
5. Department of Physiopathology, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy
Abstract:To assess the frequency of celiac-associated humoral autoimmunity in patients with long-standing childhood- and adult-onset type 1 diabetes (LDM1) and whether it occurs more frequently as the disease progresses. IgA-/IgG-anti-tissue transglutaminase (IgA-tTG and IgG-tTG) and IgA-/IgG-deamidated gliadin (DGP) antibodies were analyzed in 277 LDM1 sera (120 females; disease duration 19.3 ± 12.3 years, range 5.0–54.0 years). Of the 277 patients, 147 were childhood-onset LDM1 (CHLDM1) and 130 adult-onset LDM1 (ADLDM1); 6.1 % LDM1 sera were tTG- and/or DGP-antibody-positive, with a lower frequency among CHLDM1 as compared with ADLDM1 patients (3.4 vs 9.2 %, p = 0.048). Celiac-associated immunoreactivity was significantly more frequent in LDM1 with >15 years of disease duration (9.4 vs 2.9 % in those with ≤15 years, p = 0.042) and among them in ADLDM1 (14.7 vs 4.2 % CHLDM1, p = 0.043). Celiac disease humoral immunoreactivity should be screened not only at diabetes onset, but also in long-standing patients, especially adults with disease duration >15 years.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号